{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:44:50Z","timestamp":1792071890676,"version":"4.4.0"},"reference-count":53,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T00:00:00Z","timestamp":1231372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:p>\n                    <jats:bold>OBJECTIVES:<\/jats:bold>\n                    To evaluate whether combined use of multiple central nervous system (CNS) medications over time is associated with cognitive change.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>DESIGN:<\/jats:bold>\n                    Longitudinal cohort study.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>SETTING:<\/jats:bold>\n                    Pittsburgh, Pennsylvania, and Memphis, Tennessee.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>PARTICIPANTS:<\/jats:bold>\n                    Two thousand seven hundred thirty\u2010seven healthy adults (aged \u226565) enrolled in the Health, Aging and Body Composition study without baseline cognitive impairment (modified Mini\u2010Mental State Examination (3MS) score \u226580).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>MEASUREMENTS:<\/jats:bold>\n                    CNS medication (benzodiazepine\u2010 and opioid\u2010receptor agonists, antipsychotics, antidepressants) use, duration, and dose were determined at baseline (Year 1) and Years 3 and 5. Cognitive function was measured using the 3MS at baseline and Years 3 and 5. The outcome variables were incident cognitive impairment (3MS score &lt;80) and cognitive decline (\u22655\u2010point decline on 3MS). Multivariable interval\u2010censored survival analyses were conducted.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:<\/jats:bold>\n                    By Year 5, 7.7% of subjects had incident cognitive impairment; 25.2% demonstrated cognitive decline. CNS medication use increased from 13.9% at baseline to 15.3% and 17.1% at Years 3 and 5, respectively. It was not associated with incident cognitive impairment (adjusted hazard ratio (adj HR)=1.11, 95% confidence interval (CI)=0.73\u20131.69) but was associated with cognitive decline (adj HR 1.37, 95% CI=1.11\u20131.70). Longer duration (adj HR=1.39, CI=1.08\u20131.79) and higher doses (&gt;3 standardized daily doses) (adj HR=1.87, 95% CI=1.25\u20132.79) of CNS medications suggested greater risk of cognitive decline than with nonuse.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION:<\/jats:bold>\n                    Combined use of CNS medications, especially at higher doses, appears to be associated with cognitive decline in older adults. Future studies must explore the effect of combined CNS medication use on vulnerable older adults.\n                  <\/jats:p>","DOI":"10.1111\/j.1532-5415.2008.02127.x","type":"journal-article","created":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T11:11:07Z","timestamp":1231413067000},"page":"243-250","source":"Crossref","is-referenced-by-count":108,"title":["Effect of Central Nervous System Medication Use on Decline in Cognition in Community\u2010Dwelling Older Adults: Findings from the Health, Aging and Body Composition Study"],"prefix":"10.1111","volume":"57","author":[{"given":"Rollin M.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan F.","family":"Roumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne B.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Ruby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Studenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald I.","family":"Shorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas C.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor M.","family":"Simonsick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N.","family":"Hilmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Hanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Health, Aging and Body Composition Study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,28]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809202600514"},{"key":"e_1_2_7_3_2","first-page":"605","volume-title":"Principles and Practice of Geriatric Psychiatry","author":"Kotlyar M","year":"2006"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-2-169"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510260066030"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199915010-00002"},{"key":"e_1_2_7_7_2","first-page":"285","article-title":"Long\u2010term benzodiazepine use and cognitive decline in the elderly","volume":"22","author":"Paterniti S","year":"2002","journal-title":"The Epidemiology of Vascular Aging Study"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90059-5"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.00571.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520190064036"},{"key":"e_1_2_7_11_2","first-page":"144","article-title":"Effects of diazepam on recall memory","volume":"25","author":"Pomara N","year":"1989","journal-title":"Relationship to aging, dose, and duration of treatment"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100303"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.8.781"},{"key":"e_1_2_7_14_2","first-page":"143","article-title":"Drugs with anticholinergic properties and cognitive performance in the elderly","volume":"59","author":"Lechevallier\u2010Michel N","year":"2004","journal-title":"Results from the PAQUID Study"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.01.021"},{"key":"e_1_2_7_16_2","first-page":"715","article-title":"Walking performance and cardiovascular response","volume":"58","author":"Newman AB","year":"2003","journal-title":"Associations with age and morbidity\u2014the Health, Aging and Body Composition Study"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01719664"},{"key":"e_1_2_7_18_2","first-page":"314","article-title":"The Modified Mini\u2010Mental State (3MS) examination","volume":"48","author":"Teng EL","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000022013"},{"key":"e_1_2_7_20_2","volume-title":"Geriatric Dosage Handbook","author":"Semla TP","year":"2007"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(03)00111-2"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000073620.42047.D7"},{"key":"e_1_2_7_23_2","first-page":"506","article-title":"Mild dementia or cognitive impairment","volume":"46","author":"Bland RC","year":"2001","journal-title":"The Modified Mini-Mental State examination (3MS) as a screen for dementia"},{"issue":"1","key":"e_1_2_7_24_2","first-page":"71","article-title":"Reliable individual change scores on the 3MS in older persons with dementia","volume":"13","author":"Correa JA","year":"2001","journal-title":"Results from the Canadian Study of Health and Aging"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(03)00247-6"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02602312"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1023"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03440080075027"},{"key":"e_1_2_7_29_2","first-page":"M322","article-title":"Mild cognitive impairment in the population and physical health","volume":"55","author":"Frisoni GB","year":"2000","journal-title":"Data on 1,435 individuals aged 75 to 95"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/48.5.M181"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480060073033"},{"key":"e_1_2_7_32_2","first-page":"809","article-title":"Delirium in hospitalized older persons","volume":"42","author":"Pompei P","year":"1994","journal-title":"Outcomes and predictors"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2006.00691.x"},{"key":"e_1_2_7_34_2","first-page":"1604","article-title":"Cardiovascular disease and distribution of cognitive function in elderly people","volume":"308","author":"Breteler MM","year":"1994","journal-title":"The Rotterdam Study"},{"key":"e_1_2_7_35_2","first-page":"1246","article-title":"Cerebral white matter lesions, vascular risk factors, and cognitive function in a population\u2010based study","volume":"44","author":"Breteler MM","year":"1994","journal-title":"The Rotterdam Study"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02598279"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-6-199309150-00005"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530350034031"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1047-2797(96)00124-X"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1999.tb01603.x"},{"key":"e_1_2_7_41_2","volume-title":"The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability","author":"Kasper JD","year":"1995"},{"key":"e_1_2_7_42_2","first-page":"1833","article-title":"Validation study of WOMAC","volume":"15","author":"Bellamy N","year":"1988","journal-title":"A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee"},{"key":"e_1_2_7_43_2","first-page":"151","article-title":"Level of physical activity and the risk of radiographic and symptomatic knee osteoarthritis in the elderly","volume":"106","author":"McAlindon TE","year":"1999","journal-title":"The Framingham Study"},{"key":"e_1_2_7_44_2","first-page":"566","article-title":"Inflammatory markers and depressed mood in older persons","volume":"54","author":"Penninx BWJH","year":"2003","journal-title":"Results from the Health, Aging and Body Composition Study"},{"key":"e_1_2_7_45_2","first-page":"283","article-title":"Interval\u2010censored survival data","volume":"15","author":"Farrington CP.","year":"1996","journal-title":"A generalized linear modeling approach"},{"key":"e_1_2_7_46_2","volume-title":"Applied Survival Analysis","author":"Hosmer DW","year":"1999"},{"key":"e_1_2_7_47_2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2307\/2533514","article-title":"Hazard regression with interval\u2010censored data","volume":"53","author":"Kooperberg C","year":"1996","journal-title":"Biometrics"},{"key":"e_1_2_7_48_2","unstructured":"HanlonJT BoudreauRM RoumaniYet al.The impact of central nervous system medication dosage on recurrent falls in community elders: The Health Aging and Body Composition Study. J Gerontol Med Sci2008(in press)"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.06.022"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/58.1.M76"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnf.0000240949.41691.95"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.43.1.31"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1159\/000109915"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.acn.2004.12.003"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1532-5415.2008.02127.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1532-5415.2008.02127.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T15:08:27Z","timestamp":1762182507000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1532-5415.2008.02127.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,28]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1532-5415.2008.02127.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1532-5415.2008.02127.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,28]]}}}